Glaucoma: Adverse event on use of topiramate in alcohol de-addiction

Indian Journal of Psychiatry

Volumn 53, Issue 2, 2011, Pages 163-165

  Pai, Keshava ^a   Rajashekaran, Pooja ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Glaucoma; Side effects; Topiramate

Indexed keywords

ACETAZOLAMIDE; ANTIGLAUCOMA AGENT; BENALGIS; CHLORDIAZEPOXIDE; PREDNISOLONE; THIAMINE DERIVATIVE; TIMOLOL; TOPIRAMATE; UNCLASSIFIED DRUG;

ADULT; ADVERSE OUTCOME; ALCOHOLISM; ARTICLE; CASE REPORT; CHEMOSIS; CLOSED ANGLE GLAUCOMA; CORNEA EDEMA; DISEASE SEVERITY; DRUG WITHDRAWAL; EPIPHORA; ERYTHEMA; EYE EXAMINATION; EYE PAIN; FOLLOW UP; GONIOSCOPY; HOSPITAL DISCHARGE; HUMAN; INTRAOCULAR PRESSURE; MALE; MYDRIASIS; OPHTHALMOSCOPY; VISUAL ACUITY; VISUAL DISORDER;

EID: 79960254652     PISSN: 00195545     EISSN: 19983794     Source Type: Journal    
DOI: 10.4103/0019-5545.82552     Document Type: Article

References (25)

1. Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Ophthalmol 2001;132:112-4. (Pubitemid 32600901)
2. Chalam KV, Tillis T, Syed F, Agarwal S, Brar VS. Acute bilateral simultaneous angle closure glaucomaafter topiramate administration: A casereport. J Med Case Reports 2008;2:1.
3. Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol 2004;137:193-5. (Pubitemid 38045216)
4. Guier CP. Elevated intraocular pressure and myopic shift linked to topiramate use. Optom Vis Sci 2007;84:1070-3.
5. Levy J, Yagev R, Petrova A, Lifshitz T. Topiramate induced bilateral angleclosure glaucoma. Can J Ophthalmol 2006;41:221-5.
6. Bhattacharyya KB, Basu S. Acute myopia induced by topiramate: Report of a case and review of the literature. Neurol India 2005;53:108-9. (Pubitemid 40545216)
7. Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-associatedacute, bilateral, secondary angle-closure glaucoma. Ophthalmology 2004;111:109-11. (Pubitemid 38032217)
8. Fourman S. Angle-closure glaucoma complicating cilio-choroidal detachment. Ophthalmology 1989;96:646-53. (Pubitemid 19119471)
9. Markind JE. Topiramate: A new antiepileptic drug. Am J Health Syst Pharm 1998;55:554-62. (Pubitemid 28129017)
10. Sachi D, Vijaya L. Topiramate induced secondary angle closure glaucoma. J Postgrad Med 2006;52:72-3.
11. Arnone D. Review of the use of Topiramate for treatment of psychiatric disorders. Ann GenPsychiatry2005;4:5.
12. Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ. Oral Topiramate Reduces the Consequences of Drinking and Improves the Quality of Lifeof Alcohol-Dependent Individuals: A Randomized Controlled Trial. Arch Gen Psychiatry 2004;61:905-12. (Pubitemid 39181080)
13. Shorvon SD. Safety of topiramate: adverse events and relationships to dosing. Epilepsia 1996;37:S18-22. (Pubitemid 26192219)
14. Aminlari A, East M, Wei W, Quillen D. Topiramate induced acute angle closure glaucoma. Open Ophthalmol J 2008;2:46-7.
15. Desai CM, Ramchandani SJ, Bhopale SG, Ramchandani SS. Acute myopia and angle closure caused by topiramate, a drug used for prophylaxis of migraine. Indian J Ophthalmol 2006;54:195-7.
16. Gawley SD. Topiramate induced acute transient myopia: A case report. Cases J 2009;2:7430
17. Singh SK, Thapa SS, Badhu BP. Topiramate induced bilateral angleclosure glaucoma. Kathmandu Univ Med J (KUMJ) 2007;5:18:234-6. (Pubitemid 351500386)
18. Boonyaleephan Sumalee. Bilateral Acute Onset Myopia and Angle Closure Glaucoma after Oral Topiramate: A Case Report. J Med Assoc Thai 2008;91:1904-7.
19. Thambi L, Kapcala LP, Chambers W, Nourjah P, Beitz J, Chen M, et al. Topiramate-associated secondary angle-closure glaucoma: a case series. Arch Ophthalmol 2002;120:1108. (Pubitemid 34856090)
20. Chen TC, Chao CW, Sorkin JA. Topiramate induced myopic shift and angle closure glaucoma. Br J Ophthalmol 2003;87:648-9. (Pubitemid 36535347)
21. Liebmann JM, Weinreb RN, Ritch R. Angle-closure glaucoma associated with occult annular ciliary body detachment. Arch Ophthalmol 1998;116:731-5. (Pubitemid 28292725)
22. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. ClinPharmacolTher 1981;30:239-45. (Pubitemid 12149145)
23. World Health Organization. Uppsala Monitoring Center. Causality Assessment of Suspected Adverse Reactions. Available from: http://www.who-umc. org/DynPage.aspx?id=22682 [Last accessed on 2011 Feb 28].
24. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49: 2229-32.
25. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992;27:538.